Gocuk Sena A, Jolly Jasleen K, Edwards Thomas L, Ayton Lauren N
Department of Optometry and Vision Sciences, The University of Melbourne, Melbourne, Victoria, Australia; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia; Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.
Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.
Prog Retin Eye Res. 2023 Sep;96:101190. doi: 10.1016/j.preteyeres.2023.101190. Epub 2023 Jul 3.
Inherited retinal diseases (IRDs) are a group of heterogeneous conditions that cause progressive vision loss, typically due to monogenic mutations. Female carriers of X-linked IRDs have a single copy of the disease-causing gene, and therefore, may exhibit variable clinical signs that vary from near normal retina to severe disease and vision loss. The relationships between individual genetic mutations and disease severity in X-linked carriers requires further study. This review summarises the current literature surrounding the spectrum of disease seen in female carriers of choroideremia and X-linked retinitis pigmentosa. Various classification systems are contrasted to accurately grade retinal disease. Furthermore, genetic mechanisms at the early embryonic stage are explored to potentially explain the variability of disease seen in female carriers. Future research in this area will provide insight into the association between genotype and retinal phenotypes of female carriers, which will guide in the management of these patients. This review acknowledges the importance of identifying which patients may be at high risk of developing severe symptoms, and therefore should be considered for emerging treatments, such as retinal gene therapy.
遗传性视网膜疾病(IRDs)是一组异质性疾病,通常由于单基因突导致视力逐渐丧失。X连锁IRDs的女性携带者有一个致病基因拷贝,因此,可能表现出从接近正常视网膜到严重疾病和视力丧失的不同临床体征。X连锁携带者中个体基因突变与疾病严重程度之间的关系需要进一步研究。本综述总结了目前关于脉络膜视网膜炎和X连锁视网膜色素变性女性携带者疾病谱的文献。对比了各种分类系统以准确分级视网膜疾病。此外,还探讨了早期胚胎阶段的遗传机制,以潜在解释女性携带者中所见疾病的变异性。该领域的未来研究将深入了解女性携带者的基因型与视网膜表型之间的关联,这将指导这些患者的管理。本综述认识到识别哪些患者可能有发展为严重症状的高风险的重要性,因此应考虑采用新兴治疗方法,如视网膜基因治疗。